secwatch.observer — SEC 8-K summary
======================================

Issuer:     COMPASS Pathways plc (CMPS)
CIK:        0001816590
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0001628280-24-033854
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Compass Pathways Q2 net loss $38.1M; COMP005 phase 3 TRD data expected Q4 2024
------------------------------------------------------------------------------

- Net loss of $38.1M ($0.56 per share) vs $28.3M in Q2 2023; R&D expenses rose to $29.1M.
- Cash position $228.6M as of June 30, 2024; full-year 2024 operating cash burn guided $110M-$130M.
- Top-line COMP005 pivotal phase 3 data in treatment-resistant depression expected Q4 2024.
- Gino Santini appointed Chairman of Board effective September 3, 2024; Lori Englebert named CCO.
- Phase 2 PTSD study showed sustained symptom improvement; exploring optimal path forward.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816590/000162828024033854/0001628280-24-033854-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816590/000162828024033854/cmps-20240730.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-033854

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer